These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6139893)

  • 1. [Electrical properties of a new beta-blocker agent, tertatolol, in man].
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Therapie; 1983; 38(4):371-8. PubMed ID: 6139893
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
    Solti F; Czakó E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):229-32. PubMed ID: 6104635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic properties of intravenous Tenormine in man.
    Di Biase M; Favale S; Rizzon P
    Eur J Cardiol; 1979 Apr; 9(4):333-42. PubMed ID: 34520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of Atenolol and Propranolol on sinus node and intracardiac conduction in man (author's transl)].
    Seipel L; Breithardt G; Döhring HP
    Z Kardiol; 1977 Dec; 66(12):719-25. PubMed ID: 602355
    [No Abstract]   [Full Text] [Related]  

  • 5. [Local propranolol blocking of the beta-adrenergic receptors of the sinoatrial node during intravenous infusion of isoproterenol. Experimental research].
    Mezzacapo B; Massaria E; Di Fabio D
    Minerva Cardioangiol; 1969 Dec; 17(12):1074-9. PubMed ID: 4392066
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of electrophysiological effects of betaxolol].
    Ponsonnaille J; Citron B; Trolese JF; Serignat B; Gras H
    Ann Cardiol Angeiol (Paris); 1987 Mar; 36(3):149-53. PubMed ID: 2882723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of calcium ions on the rhythmic and contractile activities of the heart].
    Abinder AA; Khitrov NK; Aslaniants ZhE; Svistukhin AI
    Fiziol Zh SSSR Im I M Sechenova; 1975 Jan; 61(1):117-23. PubMed ID: 234088
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical electrophysiological properties of penbutolol: a non-selective beta-blocking agent.
    von Leitner ER; Biamino G
    Eur J Cardiol; 1980; 12(2):121-8. PubMed ID: 7439238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why another beta-antagonist?
    Fitzgerald JD
    Postgrad Med J; 1977; 53 Suppl 3():52-7. PubMed ID: 22072
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of tertatolol on atherogenicity indices in normo- or dis-lipemic hypertensive patients].
    Richard JL; Jacotot B
    Ann Med Interne (Paris); 1987; 138 Suppl 1():35-8. PubMed ID: 2884915
    [No Abstract]   [Full Text] [Related]  

  • 12. [Structure of the sinus dysfunction in hypertensive patients].
    Tuev AV; Poteshkina NG; Grigoriadi NE
    Ter Arkh; 2004; 76(8):36-8. PubMed ID: 15471394
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of beta-adrenergic receptors can explain the lack of rebound effect after tertatolol withdrawal.
    De Blasi A; Pittana PL; Fratelli M; Garattini S
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):257S-260S. PubMed ID: 2573373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a new adrenergic beta receptor blocker ACC-9089 on transmembrane potential of canine Purkinje fibers in comparison with propranolol].
    Tan YH; Wit AL
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):82-7. PubMed ID: 2867664
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
    Mayer O; Cepelák V; Vitous J; Potmĕsil J
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of beta receptor blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) on the circulatory system during intubation for general anesthesia].
    Kim SY; Miyamoto K; Yoshikawa K
    Masui; 1975 Aug; 24(8):780-6. PubMed ID: 240954
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-adrenergic receptor changes during tertatolol treatment in healthy volunteers: relevance for beta-blocking therapy.
    De Blasi A; Lipartiti M; Garattini S
    Am J Nephrol; 1986; 6 Suppl 2():69-73. PubMed ID: 2879475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental analysis of antihypertensive properties of S 5984 and its constituents: tertatolol and indapamide.
    Marmo E; Lampa E; Rosatti F; Berrino L; Russo S; Romano AR; Matera C
    Drugs Exp Clin Res; 1985; 11(10):709-15. PubMed ID: 2873980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tertatolol on glomerular mesangial cells.
    Shultz PJ; Raij L
    J Hypertens Suppl; 1991 Dec; 9(6):S358-9. PubMed ID: 1687872
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of Tobanum on the electrophysiology of the heart].
    Tarján J; Rostás L; Wagner G; Józan M; Lascsik L
    Orv Hetil; 1981 Dec; 122(49):3005-8. PubMed ID: 6120494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.